ImmunoGen

-$0.13 (-2.30%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunoGen and other ETFs, options, and stocks.

About IMGN

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151.

CEO

Mark Joseph Enyedy

Employees

Headquarters

Waltham, Massachusetts

Founded

1981

IMGN Key Statistics

Market Cap

1.21B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.42M

High Today

$5.70

Low Today

$5.50

Open Price

$5.60

Volume

1.01M

52 Week High

$10.88

52 Week Low

$3.38

IMGN News

BenzingaJul 30

Recap: Immunogen Q2 Earnings

Shares of Immunogen (NASDAQ:IMGN) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 7.14% year over year to

Analyst Ratings

56%

of 9 ratings

Buy

55.6%

Hold

44.4%

Sell

IMGN Earnings

-$0.19

-$0.07

$0.04

$0.16

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

-$0.18 per share

Actual

-$0.15 per share

Replay Earnings Call